Navidea Biopharmaceuticals Inc Shares outstanding
What is the Shares outstanding of Navidea Biopharmaceuticals Inc?
The Shares outstanding of Navidea Biopharmaceuticals Inc is 100.084M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with shares outstanding similar to Navidea Biopharmaceuticals Inc
- Milton Capital Plc has Shares outstanding of 100.000M
- Munjal Auto Industries has Shares outstanding of 100.000M
- Beijing Jingcheng Machinery Electric has Shares outstanding of 100.000M
- Satia Industries has Shares outstanding of 100.000M
- Satia Industries has Shares outstanding of 100.000M
- Marifil Mines has Shares outstanding of 100.075M
- Navidea Biopharmaceuticals Inc has Shares outstanding of 100.084M
- Mind Gym plc has Shares outstanding of 100.106M
- Plus500 has Shares outstanding of 100.117M
- Sprouts Farmers Market Inc has Shares outstanding of 100.130M
- Simply Good Foods Co has Shares outstanding of 100.136M
- Northern Oil and Gas has Shares outstanding of 100.172M
- Premier Inc has Shares outstanding of 100.188M